Am J Trop Med Hyg

1. BWIRE G, Sack DA, Lunkuse SM, Ongole F, et al
   Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda.
   Am J Trop Med Hyg. 2023;108:954-962.
   

   >> Share

   
   
2. JAYBHAYE A, Lg S, Dash N, Verghese V, et al
   Clinical Spectrum and Microbial Etiology of Bone and Joint Infections in Children: A Retrospective Analysis from South India.
   Am J Trop Med Hyg. 2023;108:936-941.
   

   >> Share

   
   
3. DAVIS WW, Mohammed Y, Abdilahi I, Kim S, et al
   Food as a Driver of a Cholera Epidemic in Jijiga, Ethiopia-June 2017.
   Am J Trop Med Hyg. 2023;108:963-967.
   

   >> Share

   
   
4. RIVERA FP, Medina A, Riveros M, Ochoa TJ, et al
   Colonizing and Virulence Factors in Enterotoxigenic Escherichia coli from Peru.
   Am J Trop Med Hyg. 2023;108:948-953.
   

   >> Share

   
   
5. ULUSAN BAGCI O, Muftuoglu C, Guldaval F, Serce Unat D, et al
   Molecular Prevalence of Microsporidia Infection in Patients with Lung Cancer.
   Am J Trop Med Hyg. 2023;108:895-900.
   

   >> Share

   
   
6. JABEEN K, Saleem S, Nizamuddin S, Arshad F, et al
   Reporting of Azithromycin Activity against Clinical Isolates of Extensively Drug-Resistant Salmonella enterica Serovar Typhi.
   Am J Trop Med Hyg. 2023;108:942-947.
   

   >> Share

   
   
7. EL HADJI IBRAHIMA N, Diatta G, Adama Zan D, Bassene H, et al
   Quantitative Polymerase Chain Reaction from Malaria Rapid Diagnostic Tests to Detect Borrelia crocidurae, the Agent of Tick-Borne Relapsing Fever, in Febrile Patients in Senegal.
   Am J Trop Med Hyg. 2023 Mar 13:tpmd220342. doi: 10.4269/ajtmh.22-0342.
   

   >> Share

   
   

   
   Clin Infect Dis

8. JOHNSON KA, Sankaran M, Kohn RP, Bacon O, et al
   Testing for Mycoplasma Genitalium and Using Doxycycline as First-Line Therapy at Initial Presentations for Non-Gonococcal Urethritis (NGU) Correlate with Reductions in Persistent NGU.
   Clin Infect Dis. 2022 Dec 28:ciac977. doi: 10.1093.
   

   >> Share

   
   
9. GALLAGHER JC
   Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time.
   Clin Infect Dis. 2023;76:1613-1614.
   

   >> Share

   
   
10. MCATEER J, Lee JH, Cosgrove SE, Dzintars K, et al
    Defining the Optimal Duration of Therapy for Hospitalized Patients with Complicated Urinary Tract Infections and Associated Bacteremia.
    Clin Infect Dis. 2023 Jan 12:ciad009. doi: 10.1093.
    

    >> Share

    
    
11. PROCTOR RA
    Development of a Staphylococcus aureus Vaccine: An On-going Journey.
    Clin Infect Dis. 2023 Apr 29:ciad217. doi: 10.1093.
    

    >> Share

    
    
12. WATKINS RR, Bonomo RA
    Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections.
    Clin Infect Dis. 2023;76.
    

    >> Share

    
    
13. CASTANHEIRA M, Mendes RE, Gales AC
    Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.
    Clin Infect Dis. 2023;76.
    

    >> Share

    
    
14. SHIELDS RK, Paterson DL, Tamma PD
    Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
    Clin Infect Dis. 2023;76.
    

    >> Share

    
    
15. WATKINS RR, Du B, Isaacs R, Altarac D, et al
    Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial.
    Clin Infect Dis. 2023;76.
    

    >> Share

    
    
16. O'DONNELL JP, Bhavnani SM
    The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus Complex.
    Clin Infect Dis. 2023;76.
    

    >> Share

    
    
17. PAPP-WALLACE KM, McLeod SM, Miller AA
    Durlobactam, a Broad-Spectrum Serine beta-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species.
    Clin Infect Dis. 2023;76.
    

    >> Share

    
    
18. MELNYCHUK L, Perlman-Arrow S, Bastos M, Menzies D, et al
    A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events.
    Clin Infect Dis. 2023 May 1:ciad246. doi: 10.1093.
    

    >> Share

    
    
19. HASSANZADEH H, Baber J, Begier E, Noriega DC, et al
    Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STRIVE Randomized Clinical Trial.
    Clin Infect Dis. 2023 May 1:ciad218. doi: 10.1093.
    

    >> Share

    
    
20. LOUIE JK, Keh C
    Latent Tuberculosis Infection Treatment: Still a Long Road Ahead.
    Clin Infect Dis. 2023 May 1:ciad251. doi: 10.1093.
    

    >> Share

    
    
21. TIMIRE C, Pedrazzoli D, Boccia D, Houben RM, et al
    Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds.
    Clin Infect Dis. 2023 May 3:ciad273. doi: 10.1093.
    

    >> Share

    
    
22. PARAS ML
    Updating the diagnostic criteria for infective endocarditis: time for a (valve) replacement.
    Clin Infect Dis. 2023 May 4:ciad269. doi: 10.1093.
    

    >> Share

    
    
23. FOWLER VG, Durack DT, Selton-Suty C, Athan E, et al
    The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.
    Clin Infect Dis. 2023 May 4:ciad271. doi: 10.1093.
    

    >> Share

    
    
24. BOBAK CA, Botha M, Workman L, Hill JE, et al
    Gene expression in cord blood and tuberculosis in early childhood: A nested case-control study in a South African birth cohort.
    Clin Infect Dis. 2023 May 5:ciad268. doi: 10.1093.
    

    >> Share

    
    

    
    Curr Microbiol

25. SINGH I, Roshan M, Vats A, Behera M, et al
    Evaluation of Virulence, Antimicrobial Resistance and Biofilm Forming Potential of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates from Bovine Suspected with Mastitis.
    Curr Microbiol. 2023;80:198.
    

    >> Share

    
    

    
    Diagn Microbiol Infect Dis

26. OBENG-NKRUMAH N, Hansen DS, Awuah-Mensah G, Blankson NK, et al
    High level of colonization with third-generation cephalosporin-resistant Enterobacterales in African community settings, Ghana.
    Diagn Microbiol Infect Dis. 2023;106:115918.
    

    >> Share

    
    
27. ZELLNER AA, Hischebeth GT, Molitor E, Wirtz DC, et al
    Periprosthetic joint infection caused by kytococcus schroeteri: The first reported case and a review of the literature.
    Diagn Microbiol Infect Dis. 2023;106:115922.
    

    >> Share

    
    

    
    Eur J Clin Microbiol Infect Dis

28. DI BELLA S, Gatti M, Principe L
    Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
    Eur J Clin Microbiol Infect Dis. 2023 Apr 29. doi: 10.1007/s10096-023-04612.
    

    >> Share

    
    
29. NEVANLINNA V, Huttunen R, Aittoniemi J, Luukkaala T, et al
    Incidence, seasonal pattern, and clinical manifestations of Streptococcus dysgalactiae subspecies equisimilis bacteremia; a population-based study.
    Eur J Clin Microbiol Infect Dis. 2023 Apr 29. doi: 10.1007/s10096-023-04607.
    

    >> Share

    
    
30. CASTRO-LIMA VAC, Santos APT, Musqueira PT, Maluf NZ, et al
    Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.
    Eur J Clin Microbiol Infect Dis. 2023 May 1. doi: 10.1007/s10096-023-04613.
    

    >> Share

    
    
31. SALEHI Z, Sharifynia S, Jamzivar F, Shams-Ghahfarokhi M, et al
    Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
    Eur J Clin Microbiol Infect Dis. 2023 May 5. doi: 10.1007/s10096-023-04608.
    

    >> Share

    
    
32. CORREDOIRA J, Miguez E, Mateo LM, Fernandez-Rodriguez R, et al
    The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer.
    Eur J Clin Microbiol Infect Dis. 2023 May 5. doi: 10.1007/s10096-023-04618.
    

    >> Share

    
    

    
    Infect Immun

33. KRYSAN DJ
    The Mystery of Candida albicans Hyphal Morphogenesis in the Macrophage Phagolysosome.
    Infect Immun. 2023 Apr 27:e0010423. doi: 10.1128/iai.00104.
    

    >> Share

    
    

    
    J Antimicrob Chemother

34. WATKINS RR, Thapaliya D, Lemonovich TL, Bonomo RA, et al
    Gepotidacin: a novel, oral, 'first-in-class' triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea.
    J Antimicrob Chemother. 2023 Mar 8:dkad060. doi: 10.1093.
    

    >> Share

    
    
35. JIA M, Zhou W, Luo D, Xue H, et al
    Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions.
    J Antimicrob Chemother. 2023;78:1182-1190.
    

    >> Share

    
    
36. ALONSO-GARCIA I, Vazquez-Ucha JC, Lasarte-Monterrubio C, Gonzalez-Mayo E, et al
    Simultaneous and divergent evolution of resistance to cephalosporin/beta-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
    J Antimicrob Chemother. 2023;78:1195-1200.
    

    >> Share

    
    
37. CASTILLO-POLO JA, Hernandez-Garcia M, Morosini MI, Perez-Viso B, et al
    Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain.
    J Antimicrob Chemother. 2023;78:1259-1264.
    

    >> Share

    
    
38. GONZALEZ C, Volland H, Oueslati S, Niol L, et al
    Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria.
    J Antimicrob Chemother. 2023;78:1282-1287.
    

    >> Share

    
    
39. SIMJEE S, Gould G, Maduro L, Boulianne M, et al
    No change in avilamycin (Surmax(R) Premix) minimum inhibitory concentration for Clostridium perfringens isolates recovered from poultry up to 7 years post-approval in Canada.
    J Antimicrob Chemother. 2023;78:1278-1281.
    

    >> Share

    
    
40. ELIAS R, Spadar A, Hendrickx APA, Bonnin RA, et al
    Emergence of KPC-3- and OXA-181-producing ST13 and ST17 Klebsiella pneumoniae in Portugal: genomic insights on national and international dissemination.
    J Antimicrob Chemother. 2023;78:1300-1308.
    

    >> Share

    
    
41. ALFORD MA, Karlowsky JA, Adam HJ, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    

    >> Share

    
    
42. ZHANEL GG, Lynch JP, Adam HJ
    Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13.
    J Antimicrob Chemother. 2023;78.
    

    >> Share

    
    
43. ADAM HJ, Karlowsky JA, Baxter MR, Schellenberg J, et al
    Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    

    >> Share

    
    
44. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    

    >> Share

    
    
45. SCHELLENBERG JJ, Adam HJ, Baxter MR, Karlowsky JA, et al
    Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
    J Antimicrob Chemother. 2023;78.
    

    >> Share

    
    

    
    J Biol Chem

46. WAN T, Horova M, Khetrapal V, Li S, et al
    Structural Basis of DNA Binding by the WhiB-Like Transcription Factor WhiB3 in Mycobacterium tuberculosis.
    J Biol Chem. 2023 May 2:104777. doi: 10.1016/j.jbc.2023.104777.
    

    >> Share

    
    
47. ZHOU Y, Syed JH, Semchonok DA, Wright E, et al
    Solubilization, purification, and characterization of the hexameric form of phosphatidylserine synthase from Candida albicans.
    J Biol Chem. 2023 Apr 26:104756. doi: 10.1016/j.jbc.2023.104756.
    

    >> Share

    
    

    
    J Immunol

48. WANG H, Clapp B, Hoffman C, Yang X, et al
    A Single Nasal Dose Vaccination with a Brucella abortus Mutant Potently Protects against Pulmonary Infection.
    J Immunol. 2023 Apr 10:ji2300071. doi: 10.4049/jimmunol.2300071.
    

    >> Share

    
    

    
    J Med Microbiol

49. MANFREDI E, Rocca MF, Zintgraff J, Irazu L, et al
    Rapid and accurate detection of Shiga toxin-producing Escherichia coli (STEC) serotype O157 : H7 by mass spectrometry directly from the isolate, using 10 potential biomarker peaks and machine learning predictive models.
    J Med Microbiol. 2023;72.
    

    >> Share

    
    

    
    JAMA

50. SHETE PB, Tang AS, Flood J
    Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination.
    JAMA. 2023;329:1457-1459.
    

    >> Share

    
    
51. JIN J
    Screening for Latent Tuberculosis.
    JAMA. 2023;329:1526.
    

    >> Share

    
    
52. JONAS DE, Riley SR, Lee LC, Coffey CP, et al
    Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;329:1495-1509.
    

    >> Share

    
    
53. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2023;329:1487-1494.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

54. THOMAS CM, Marr JH, Durso LM, Golwalkar M, et al
    Notes from the Field: Shiga Toxin-Producing Escherichia coli O157:H7 Linked to Raw Milk Consumption Associated with a Cow-Share Arrangement - Tennessee, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:469-470.
    

    >> Share

    
    

    
    N Engl J Med

55. PIPITO L, Cascio A
    Sporotrichoid Nodular Lymphangitis from Nocardia brasiliensis.
    N Engl J Med. 2023;388:1701.
    

    >> Share

    
    

    
    Nature

56. 
    Hopes fizzle that a TB vaccine also fends off COVID.
    Nature. 2023;617:10.
    

    >> Share

    
    
57. STUKENBROCK E, Gurr S
    Address the growing urgency of fungal disease in crops.
    Nature. 2023;617:31-34.
    

    >> Share

    
    

    
    Pediatrics

58. COTTON CH, Chen SX, Hussain SH, Lara-Corrales I, et al
    Hidradenitis Suppurativa in Pediatric Patients.
    Pediatrics. 2023;151:e2022061049.
    

    >> Share

    
    
59. EL HELOU R, Landschaft A, Harper MB, Kimia AA, et al
    Bacteremia in Children With Fever and Acute Lower Extremity Pain.
    Pediatrics. 2023 Apr 4:e2022059504. doi: 10.1542/peds.2022-059504.
    

    >> Share

    
    

    
    PLoS Med

60. BALIASHVILI D, Blumberg HM, Gandhi NR, Averhoff F, et al
    Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
    PLoS Med. 2023;20:e1004121.
    

    >> Share

    
    

    
    PLoS Negl Trop Dis

61. BALAZ V, Rivory P, Hayward D, Jaensch S, et al
    Angie-LAMP for diagnosis of human eosinophilic meningitis using dog as proxy: A LAMP assay for Angiostrongylus cantonensis DNA in cerebrospinal fluid.
    PLoS Negl Trop Dis. 2023;17:e0011038.
    

    >> Share

    
    
62. VILELA R, de Hoog S, Bensch K, Bagagli E, et al
    A taxonomic review of the genus Paracoccidioides, with focus on the uncultivable species.
    PLoS Negl Trop Dis. 2023;17:e0011220.
    

    >> Share

    
    
63. WANG G, Fu R, Zhang L, Xue L, et al
    Genomic bacterial load associated with bacterial genotypes and clinical characteristics in patients with scrub typhus in Hainan Island, Southern China.
    PLoS Negl Trop Dis. 2023;17:e0011243.
    

    >> Share

    
    
64. JAUME L, Hau E, Monsel G, Mahe A, et al
    Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study.
    PLoS Negl Trop Dis. 2023;17:e0011238.
    

    >> Share

    
    

    
    PLoS One

65. FREM JA, Doumat G, Kazma J, Gharamti A, et al
    Clinical predictors of mortality in patients with pseudomonas aeruginosa infection.
    PLoS One. 2023;18:e0282276.
    

    >> Share

    
    
66. JEAMSRIPONG S, Kuldee M, Thaotumpitak V, Chuanchuen R, et al
    Antimicrobial resistance, Extended-Spectrum beta-Lactamase production and virulence genes in Salmonella enterica and Escherichia coli isolates from estuarine environment.
    PLoS One. 2023;18:e0283359.
    

    >> Share

    
    
67. ENKEL SL, Kado J, Hla TK, Salman S, et al
    Qualitative assessment of healthy volunteer experience receiving subcutaneous infusions of high-dose benzathine penicillin G (SCIP) provides insights into design of late phase clinical studies.
    PLoS One. 2023;18:e0285037.
    

    >> Share

    
    
68. NI YH, Xu ZH, Wang J
    Understanding vaccine hesitancy with PCV13 in children: Results of a survey in Shanghai, China.
    PLoS One. 2023;18:e0284810.
    

    >> Share

    
    

    
    PLoS Pathog

69. SCHOEN TJ, Calise DG, Bok JW, Giese MA, et al
    Aspergillus fumigatus transcription factor ZfpA regulates hyphal development and alters susceptibility to antifungals and neutrophil killing during infection.
    PLoS Pathog. 2023;19:e1011152.
    

    >> Share

    
    
70. JOHNSON AF, Sands JS, Trivedi KM, Russell R, et al
    Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflammation during bacterial infection.
    PLoS Pathog. 2023;19:e1011321.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

71. LEWIN GR, Kapur A, Cornforth DM, Duncan RP, et al
    Application of a quantitative framework to improve the accuracy of a bacterial infection model.
    Proc Natl Acad Sci U S A. 2023;120:e2221542120.
    

    >> Share

    
    
72. ICHO S, Ward JS, Tam J, Kociolek LK, et al
    Intestinal bile acids provide a surmountable barrier against C. difficile TcdB-induced disease pathogenesis.
    Proc Natl Acad Sci U S A. 2023;120:e2301252120.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share